Medications for Treating Nausea
Dopamine receptor antagonists such as haloperidol, metoclopramide, and prochlorperazine should be used as first-line treatment for nausea, with 5-HT3 antagonists like ondansetron added as second-line therapy for refractory symptoms. 1
First-Line Medications
Dopaminergic pathway antagonists are recommended as first-line therapy for nausea management 1:
For nausea due to bowel obstruction caused by cancer, octreotide is specifically recommended 1
Second-Line Medications
For refractory nausea, add a 5-HT3 receptor antagonist when first-line medications are insufficient 1:
Corticosteroids can be added for persistent nausea 1:
- Dexamethasone: 2-8 mg IV/PO 3-6 times daily (particularly useful in bowel obstruction or intracranial hypertension) 1
Medication Administration Strategy
For persistent nausea, switch from as-needed dosing to scheduled around-the-clock administration for at least one week 1
If nausea persists despite multiple agents, consider:
Special Considerations
For patients with prior history of nausea, prophylactic antiemetic treatment is highly recommended before the precipitating event 1, 3
For mild infusion reactions causing nausea, ondansetron 4-8 mg IV is recommended 1
Lorazepam (0.5-2 mg IV/PO every 6 hours) can be helpful specifically for anticipatory nausea 1
For patients with bowel obstruction or increased intracranial pressure, dexamethasone (2-8 mg IV/PO) is particularly effective 1
Scopolamine (1.5-3 mg topical patch every 72 hours) is useful for nausea associated with increased oral secretions 1
Common Pitfalls and Caveats
First-generation antihistamines (e.g., diphenhydramine) should be avoided for nausea as they can potentially exacerbate hypotension, tachycardia, and sedation 1
High-dose ondansetron (32 mg IV) carries risk of QT prolongation and should be avoided 4
5-HT3 antagonists like ondansetron can cause constipation, which may worsen nausea if not addressed 1
Studies have not shown newer 5-HT3 medications to be superior to older dopaminergic agents in treating nausea at the end of life, supporting the first-line use of dopamine antagonists 1
For chemotherapy-induced nausea, combination therapy with ondansetron and dexamethasone has been shown to be more effective than ondansetron monotherapy 5